Notice of Special Interest: Development of Radiotracers for Diagnosis and Clinical Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)
National Institutes of Health
Description
This grant opportunity encourages applications to create PET Radiotracers for Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) research. These radiotracers should be suitable for use in human subjects as biomarkers or in developing new drugs. The research should concentrate on new or emerging targets related to neurodegeneration. This can include developing new tracers or improving existing ones to enhance their use in AD/ADRD research.
This NOSI invites applications that propose to develop PET Radiotracers suitable for use in AD and ADRD research in human subjects as biomarkers or in drug development. The research should focus on new and/or emerging targets associated with biological processes and/or molecular pathways relevan…
Source
Grant ID
NOT-AG-22-032
Agency
National Institutes of Health
Subcategory/Subagency
National Institute on Aging
Key Dates
Opportunity Released
September 28, 2022
Similar opportunities
- Development and Evaluation of Novel Radioligands for PET and SPECT Imaging of Molecular Targets in Brain Disorders
National Institutes of Health
- Notice of Special Interest (NOSI): Novel Approaches to Characterizing and Diagnosing Alzheimer's Disease and Related Dementias
National Institutes of Health
- Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Department of Health and Human Services
- Notice of Funding Opportunity for Pre-clinical and Early Stage Clinical Development of Drug Candidates for Alzheimer's Disease
National Institutes of Health
- Notice of Funding Opportunity (NOFO) for Preclinical Testing of Drugs for Alzheimer's Disease
National Institutes of Health